Stool-based DNA testing, a new noninvasive method for colorectal cancer screening, the first report from Iran

Table 1 Demographic and clinicopathological characteristics of patients

Patients	Sex	Age (yr)	Tumor type	Tumor size (cm)	Tumor location	Stage	FOBT	Long DNA	Instability BAT-26	p16
1	M	37	A.C	10	AC	B2	+4	+	-	M
2	M	52	A.C	5	C	B2	+4	+	-	U
3	F	64	A.C	15	C	C2	+4	+	-	U
4	M	62	A.C	2	R	B1	+1	+	-	U
5	F	34	A.C	-	Sp	B2	-	+	-	U
6	M	50	A.C	10	Hp	B2	+4	-	-	U
7	M	52	A.C	7	R	C2	-	+	-	U
8	M	70	A.C	3	AC	B2	+2	-	-	U
9	M	83	A.C	1	R	-	+2	-	-	U
10	F	50	A.C	1.5	Sp	B2	+4	+	-	U
11	M	64	A.C	3	R	C2	+3	+	-	M
12	M	83	A.C	4.5	R	-	+4	+	-	M
13	M	72	A.C	8	C	B2	+4	+	-	U
14	M	64	A.C	3	R	C2	+2	+	-	M
15	F	73	A.C	6	-	B1	+4	+	-	U
16	M	43	A.C	7	AC	B1	-	+	-	U
17	F	67	A.C	3.5	AC	B2	+4	-	-	U
18	F	53	A.C	8	Sp	C2	+4	+	-	M
19	M	49	A.C	3	C	B2	+4	-	-	U
20	F	70	A.C	5	R	B2	+3	-	-	U
21	M	51	A.C	6	R	B2	+4	-	-	U

R: Rectum; C: Cecum; AC: Ascending colon; Sp: Splenic flexure; Hp: Hepatic flexure; A.C: Adenocarcinoma; FOBT: Fecal occult blood test. M: Methylated; U: Unmethylated.